Point-of-Care Molecular Diagnostics Market Size, Share, Growth, and Industry Analysis, By Type (PCR-based, Genetic Sequencing-based, Hybridization-based, Microarray-based), By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other), Regional Insights and Forecast to 2035
Table of Content
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Point-of-Care Molecular Diagnostics Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Point-of-Care Molecular Diagnostics Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Point-of-Care Molecular Diagnostics Business Mode and Production Process
2.3.1 Point-of-Care Molecular Diagnostics Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Point-of-Care Molecular Diagnostics Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Point-of-Care Molecular Diagnostics
2.4.2 Raw Material Cost of Point-of-Care Molecular Diagnostics
2.4.3 Labor Cost of Point-of-Care Molecular Diagnostics
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Point-of-Care Molecular Diagnostics Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Point-of-Care Molecular Diagnostics Price by Manufacturer (2021-2026)
4.4 Point-of-Care Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Point-of-Care Molecular Diagnostics, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Point-of-Care Molecular Diagnostics, Product Offered and Application
4.7 Point-of-Care Molecular Diagnostics Market Competitive Situation and Trends
4.7.1 Point-of-Care Molecular Diagnostics Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Point-of-Care Molecular Diagnostics Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Point-of-Care Molecular Diagnostics Market Historical Development by Geographic Region (2021-2026)
5.1 Global Point-of-Care Molecular Diagnostics Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Point-of-Care Molecular Diagnostics Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.3.1 North America Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.3.2 North America Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.3.3 United States Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.4.1 Europe Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.4.2 Europe Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.4.3 Germany Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.5.1 Asia Pacific Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.5.3 China Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.6.1 Latin America Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.6.2 Latin America Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.6.3 Mexico Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.7.3 GCC Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
6 Global Point-of-Care Molecular Diagnostics Market Historical Development by Product Type (2021-2026)
6.1 Point-of-Care Molecular Diagnostics Definition by Type
6.2 Global Point-of-Care Molecular Diagnostics Historical Sales Volume by Product Type (2021-2026)
6.3 Global Point-of-Care Molecular Diagnostics Historical Revenue by Product Type (2021-2026)
6.4 Global Point-of-Care Molecular Diagnostics Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of PCR-based (2021-2026)
6.5.2 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Genetic Sequencing-based (2021-2026)
6.5.3 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Hybridization-based (2021-2026)
6.5.4 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Microarray-based (2021-2026)
7 Global Point-of-Care Molecular Diagnostics Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Point-of-Care Molecular Diagnostics Historical Sales Volume by End User (2021-2026)
7.3 Global Point-of-Care Molecular Diagnostics Historical Revenue by End User (2021-2026)
7.4 Global Point-of-Care Molecular Diagnostics Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Infectious Diseases (2021-2026)
7.5.2 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Oncology (2021-2026)
7.5.3 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Hematology (2021-2026)
7.5.4 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Prenatal Testing (2021-2026)
7.5.5 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Endocrinology (2021-2026)
7.5.6 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Other (2021-2026)
8 Leading Companies Profiles
8.1 Novartis AG
8.1.1 Novartis AG Corporation Information
8.1.2 Novartis AG - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.1.3 Novartis AG Performance Analysis (2021-2026)
8.1.4 Novartis AG Business and Markets Served
8.1.5 Novartis AG Recent Developments
8.2 Bayer AG
8.2.1 Bayer AG Corporation Information
8.2.2 Bayer AG - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.2.3 Bayer AG Performance Analysis (2021-2026)
8.2.4 Bayer AG Business and Markets Served
8.2.5 Bayer AG Recent Developments
8.3 Bio-Rad Laboratories Inc.
8.3.1 Bio-Rad Laboratories Inc. Corporation Information
8.3.2 Bio-Rad Laboratories Inc. - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.3.3 Bio-Rad Laboratories Inc. Performance Analysis (2021-2026)
8.3.4 Bio-Rad Laboratories Inc. Business and Markets Served
8.3.5 Bio-Rad Laboratories Inc. Recent Developments
8.4 Danaher Corporation
8.4.1 Danaher Corporation Corporation Information
8.4.2 Danaher Corporation - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.4.3 Danaher Corporation Performance Analysis (2021-2026)
8.4.4 Danaher Corporation Business and Markets Served
8.4.5 Danaher Corporation Recent Developments
8.5 Siemens Healthcare GmbH
8.5.1 Siemens Healthcare GmbH Corporation Information
8.5.2 Siemens Healthcare GmbH - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.5.3 Siemens Healthcare GmbH Performance Analysis (2021-2026)
8.5.4 Siemens Healthcare GmbH Business and Markets Served
8.5.5 Siemens Healthcare GmbH Recent Developments
8.6 Qiagen
8.6.1 Qiagen Corporation Information
8.6.2 Qiagen - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.6.3 Qiagen Performance Analysis (2021-2026)
8.6.4 Qiagen Business and Markets Served
8.6.5 Qiagen Recent Developments
8.7 Alere Inc.
8.7.1 Alere Inc. Corporation Information
8.7.2 Alere Inc. - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.7.3 Alere Inc. Performance Analysis (2021-2026)
8.7.4 Alere Inc. Business and Markets Served
8.7.5 Alere Inc. Recent Developments
8.8 Becton Dickinson Co.
8.8.1 Becton Dickinson Co. Corporation Information
8.8.2 Becton Dickinson Co. - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.8.3 Becton Dickinson Co. Performance Analysis (2021-2026)
8.8.4 Becton Dickinson Co. Business and Markets Served
8.8.5 Becton Dickinson Co. Recent Developments
9 Global Point-of-Care Molecular Diagnostics Market Forecast by Product Type and End User (2026-2034)
9.1 Global Point-of-Care Molecular Diagnostics Market Forecast by Product Type (2026-2034)
9.1.1 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of PCR-based (2026-2034)
9.1.2 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Genetic Sequencing-based (2026-2034)
9.1.3 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Hybridization-based (2026-2034)
9.1.4 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Microarray-based (2026-2034)
9.2 Global Point-of-Care Molecular Diagnostics Market Forecast by End User (2026-2034)
9.2.1 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Infectious Diseases (2026-2034)
9.2.2 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Oncology (2026-2034)
9.2.3 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Hematology (2026-2034)
9.2.4 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Prenatal Testing (2026-2034)
9.2.5 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Endocrinology (2026-2034)
9.2.6 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Other (2026-2034)
10 Global Point-of-Care Molecular Diagnostics Market Forecast by Geographic Region (2026-2034)
10.1 Global Point-of-Care Molecular Diagnostics Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Point-of-Care Molecular Diagnostics Market Size
1.3 Market Segmentation
1.4 Regulatory Environment
2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Point-of-Care Molecular Diagnostics Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Point-of-Care Molecular Diagnostics Business Mode and Production Process
2.3.1 Point-of-Care Molecular Diagnostics Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Point-of-Care Molecular Diagnostics Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Point-of-Care Molecular Diagnostics
2.4.2 Raw Material Cost of Point-of-Care Molecular Diagnostics
2.4.3 Labor Cost of Point-of-Care Molecular Diagnostics
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis
3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War
4 Market Competitive Landscape
4.1 Global Point-of-Care Molecular Diagnostics Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Point-of-Care Molecular Diagnostics Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Point-of-Care Molecular Diagnostics Price by Manufacturer (2021-2026)
4.4 Point-of-Care Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Point-of-Care Molecular Diagnostics, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Point-of-Care Molecular Diagnostics, Product Offered and Application
4.7 Point-of-Care Molecular Diagnostics Market Competitive Situation and Trends
4.7.1 Point-of-Care Molecular Diagnostics Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Point-of-Care Molecular Diagnostics Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans
5 Global Point-of-Care Molecular Diagnostics Market Historical Development by Geographic Region (2021-2026)
5.1 Global Point-of-Care Molecular Diagnostics Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Point-of-Care Molecular Diagnostics Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.3.1 North America Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.3.2 North America Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.3.3 United States Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.4.1 Europe Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.4.2 Europe Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.4.3 Germany Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.5.1 Asia Pacific Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.5.3 China Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.6.1 Latin America Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.6.2 Latin America Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.6.3 Mexico Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Point-of-Care Molecular Diagnostics Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Point-of-Care Molecular Diagnostics Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Point-of-Care Molecular Diagnostics Revenue by Country (2021-2026)
5.7.3 GCC Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Point-of-Care Molecular Diagnostics Sales Volume, Revenue and Growth (2021-2026)
6 Global Point-of-Care Molecular Diagnostics Market Historical Development by Product Type (2021-2026)
6.1 Point-of-Care Molecular Diagnostics Definition by Type
6.2 Global Point-of-Care Molecular Diagnostics Historical Sales Volume by Product Type (2021-2026)
6.3 Global Point-of-Care Molecular Diagnostics Historical Revenue by Product Type (2021-2026)
6.4 Global Point-of-Care Molecular Diagnostics Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of PCR-based (2021-2026)
6.5.2 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Genetic Sequencing-based (2021-2026)
6.5.3 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Hybridization-based (2021-2026)
6.5.4 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Microarray-based (2021-2026)
7 Global Point-of-Care Molecular Diagnostics Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Point-of-Care Molecular Diagnostics Historical Sales Volume by End User (2021-2026)
7.3 Global Point-of-Care Molecular Diagnostics Historical Revenue by End User (2021-2026)
7.4 Global Point-of-Care Molecular Diagnostics Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Infectious Diseases (2021-2026)
7.5.2 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Oncology (2021-2026)
7.5.3 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Hematology (2021-2026)
7.5.4 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Prenatal Testing (2021-2026)
7.5.5 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Endocrinology (2021-2026)
7.5.6 Global Point-of-Care Molecular Diagnostics Historical Sales Volume, Revenue and Growth Rate of Other (2021-2026)
8 Leading Companies Profiles
8.1 Novartis AG
8.1.1 Novartis AG Corporation Information
8.1.2 Novartis AG - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.1.3 Novartis AG Performance Analysis (2021-2026)
8.1.4 Novartis AG Business and Markets Served
8.1.5 Novartis AG Recent Developments
8.2 Bayer AG
8.2.1 Bayer AG Corporation Information
8.2.2 Bayer AG - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.2.3 Bayer AG Performance Analysis (2021-2026)
8.2.4 Bayer AG Business and Markets Served
8.2.5 Bayer AG Recent Developments
8.3 Bio-Rad Laboratories Inc.
8.3.1 Bio-Rad Laboratories Inc. Corporation Information
8.3.2 Bio-Rad Laboratories Inc. - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.3.3 Bio-Rad Laboratories Inc. Performance Analysis (2021-2026)
8.3.4 Bio-Rad Laboratories Inc. Business and Markets Served
8.3.5 Bio-Rad Laboratories Inc. Recent Developments
8.4 Danaher Corporation
8.4.1 Danaher Corporation Corporation Information
8.4.2 Danaher Corporation - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.4.3 Danaher Corporation Performance Analysis (2021-2026)
8.4.4 Danaher Corporation Business and Markets Served
8.4.5 Danaher Corporation Recent Developments
8.5 Siemens Healthcare GmbH
8.5.1 Siemens Healthcare GmbH Corporation Information
8.5.2 Siemens Healthcare GmbH - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.5.3 Siemens Healthcare GmbH Performance Analysis (2021-2026)
8.5.4 Siemens Healthcare GmbH Business and Markets Served
8.5.5 Siemens Healthcare GmbH Recent Developments
8.6 Qiagen
8.6.1 Qiagen Corporation Information
8.6.2 Qiagen - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.6.3 Qiagen Performance Analysis (2021-2026)
8.6.4 Qiagen Business and Markets Served
8.6.5 Qiagen Recent Developments
8.7 Alere Inc.
8.7.1 Alere Inc. Corporation Information
8.7.2 Alere Inc. - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.7.3 Alere Inc. Performance Analysis (2021-2026)
8.7.4 Alere Inc. Business and Markets Served
8.7.5 Alere Inc. Recent Developments
8.8 Becton Dickinson Co.
8.8.1 Becton Dickinson Co. Corporation Information
8.8.2 Becton Dickinson Co. - Point-of-Care Molecular Diagnostics Product Portfolio and Specification
8.8.3 Becton Dickinson Co. Performance Analysis (2021-2026)
8.8.4 Becton Dickinson Co. Business and Markets Served
8.8.5 Becton Dickinson Co. Recent Developments
9 Global Point-of-Care Molecular Diagnostics Market Forecast by Product Type and End User (2026-2034)
9.1 Global Point-of-Care Molecular Diagnostics Market Forecast by Product Type (2026-2034)
9.1.1 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of PCR-based (2026-2034)
9.1.2 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Genetic Sequencing-based (2026-2034)
9.1.3 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Hybridization-based (2026-2034)
9.1.4 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Microarray-based (2026-2034)
9.2 Global Point-of-Care Molecular Diagnostics Market Forecast by End User (2026-2034)
9.2.1 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Infectious Diseases (2026-2034)
9.2.2 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Oncology (2026-2034)
9.2.3 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Hematology (2026-2034)
9.2.4 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Prenatal Testing (2026-2034)
9.2.5 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Endocrinology (2026-2034)
9.2.6 Global Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth Rate of Other (2026-2034)
10 Global Point-of-Care Molecular Diagnostics Market Forecast by Geographic Region (2026-2034)
10.1 Global Point-of-Care Molecular Diagnostics Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Point-of-Care Molecular Diagnostics Sales Volume, Revenue Forecast and Growth (2026-2034)
11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
Our Clients
